These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1529995)

  • 1. Model for evaluating costs associated with i.v. drug delivery systems.
    Kappeler KH; Birdwell SW; Scheckelhoff DJ; Reilly CH
    Am J Hosp Pharm; 1992 Jun; 49(6):1478-81. PubMed ID: 1529995
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost comparison of oral, nasogastric, and intramuscular cimetidine drug delivery systems.
    Lau NC; Caldwell RD; Arford PH
    Hosp Pharm; 1992 Nov; 27(11):946-7, 950-2, 954-6 passim. PubMed ID: 10122039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effective and efficient delivery of medications through multi-dose i.v. pumps.
    Fulmer DB; Chisholm K
    Can J Hosp Pharm; 1995 Dec; 48(6):356-8. PubMed ID: 10153869
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple-regression hospitalization-cost model for pharmacy cost analysis.
    Phillips MS; Bradham DD; Williams RB; Petry ML
    Am J Hosp Pharm; 1986 Mar; 43(3):676-81. PubMed ID: 3085484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost analysis of mixing clindamycin and aminoglycosides.
    Abel SR; Olson SM
    Am J Hosp Pharm; 1987 Jun; 44(6):1385-7. PubMed ID: 3618617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists are not just pill-counters.
    Koncel JA
    Hospitals; 1980 Apr; 54(7):162-6. PubMed ID: 7358357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Principles and methods of managerial cost-accounting systems.
    Suver JD; Cooper JC
    Am J Hosp Pharm; 1988 Jan; 45(1):146-52. PubMed ID: 3348229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial tools in evaluating profit and DRG cost determination.
    Wilson CN
    Hosp Pharm; 1984 Jun; 19(6):438-9. PubMed ID: 10310618
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacy status v standards: an updated survey.
    Jeffrey LP; Gallina JN
    Curr Concepts Hosp Pharm Manage; 1984; 6(1):9-11. PubMed ID: 10310369
    [No Abstract]   [Full Text] [Related]  

  • 10. Variable cost per dose of preparing and administering small-volume cephalosporin admixtures. Veterans Administration Pharmacy Service Study Group.
    Am J Hosp Pharm; 1984 Dec; 41(12):2624-34. PubMed ID: 6517086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost comparison of two systems for intermittent intravenous administration of small-volume injections.
    Reilly RT; Strand LM; Bair JN
    Am J Hosp Pharm; 1985 Feb; 42(2):323-8. PubMed ID: 3976678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of pharmacy personnel to positively impact hospital finances.
    Hutchinson RA; Hatoum HT; Kolinski R; Riley DW
    Hosp Formul; 1989 Aug; 24(8):450, 453. PubMed ID: 10294357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation and cost analysis of a syringe pump system for intermittent i.v. drug delivery.
    Colangelo A; Clark ST; Janousek JP
    Am J Hosp Pharm; 1985 Mar; 42(3):581-4. PubMed ID: 3985021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug cost review--1987.
    Mehl B
    Hosp Pharm; 1988 Mar; 23(3):282-3. PubMed ID: 10318046
    [No Abstract]   [Full Text] [Related]  

  • 15. Hospital pharmacy symposium on new concepts in parenteral drug delivery.
    Anderson RW; Cohen JE; Cohen MR; Kleinberg ML; Lewis GR; McAllister JC; Turco SJ
    Hosp Pharm; 1986 Nov; 21(11):1033-6, 1043-6, 1052-5. PubMed ID: 10317801
    [No Abstract]   [Full Text] [Related]  

  • 16. Outsourcing inpatient i.v. compounding: expense and medication error implications.
    Burruss RA; Carroll NV; Schraa C; Burton B
    Pharm Pract Manag Q; 1996 Oct; 16(3):52-9. PubMed ID: 10166235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appraisal of drug costs to hospitals.
    Salman L
    J Hosp Dent Pract; 1979; 13(1):5-9. PubMed ID: 296180
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect on drug costs of implementing decentralized drug distribution.
    Roberts AW
    Am J Hosp Pharm; 1983 Apr; 40(4):604-6. PubMed ID: 6846367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The case for the heparin flush.
    Cyganski JM; Donahue JM; Heaton JS
    Am J Nurs; 1987 Jun; 87(6):796-7. PubMed ID: 3647723
    [No Abstract]   [Full Text] [Related]  

  • 20. Investigational drug protocols--hidden costs.
    Mehl B
    Hosp Pharm; 1991 May; 26(5):459-61. PubMed ID: 10110663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.